Correlation Between Anebulo Pharmaceuticals and Fennec Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Fennec Pharmaceuticals.

Diversification Opportunities for Anebulo Pharmaceuticals and Fennec Pharmaceuticals

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Anebulo and Fennec is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Fennec Pharmaceuticals go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Fennec Pharmaceuticals

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 1.91 times more return on investment than Fennec Pharmaceuticals. However, Anebulo Pharmaceuticals is 1.91 times more volatile than Fennec Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest  257.00  in Anebulo Pharmaceuticals on November 3, 2024 and sell it today you would lose (103.40) from holding Anebulo Pharmaceuticals or give up 40.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Anebulo Pharmaceuticals  vs.  Fennec Pharmaceuticals

 Performance 
       Timeline  
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Fennec Pharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Fennec Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point.

Anebulo Pharmaceuticals and Fennec Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anebulo Pharmaceuticals and Fennec Pharmaceuticals

The main advantage of trading using opposite Anebulo Pharmaceuticals and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.
The idea behind Anebulo Pharmaceuticals and Fennec Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities